Effectiveness of Pulmonary Vein Isolation in Prevention of Atrial Fibrillation Following Heart Bypass Surgery
Atrial Fibrillation
About this trial
This is an interventional prevention trial for Atrial Fibrillation focused on measuring Effectiveness, Pulmonary Vein Isolation Procedure, Coronary Artery Bypass Surgery, Atrial Fibrillation
Eligibility Criteria
Inclusion Criteria: Adult patients (Age>=18) undergoing elective coronary artery bypass grafting with cardiopulmonary bypass by 4 surgeons at the London Health Sciences Centre Patients at high risk of developing postoperative atrial fibrillation--patients are required to meet one or more of the following criteria: Age >=65 Ejection Fraction <50% or Left Ventricle Grade of 2-3 Diabetes Mellitus (independent of type of management) Exclusion Criteria: Any documented prior history of atrial fibrillation (paroxysmal/chronic) Contraindication to Beta Blockers Severe COPD with intolerance to Beta Blockers Concomitant non-CABG procedure Enrollment in another RCT Inability to obtain informed consent Patients' inability to attend follow-up visits Grade IV left ventricle (EF <20%) Redo CABG procedure Off-pump coronary artery bypass surgery
Sites / Locations
- London Health Sciences Centre, University Hospital
Arms of the Study
Arm 1
Experimental
A
Prophylactic Pulmonary Vein Isolation in Addition to CABG for the prevention of postoperative Atrial Fibrillation